Keywords: مونوآمین حامل 2; 6-OHDA; 6-hydroxydopamine; α-syn; α-synuclein; ACC; Anterior Cingulate Cortex; ADMA; asymmetric dimethylarginine; Alda-1; N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide; Aldh1/Aldh2; aldehyde dehydrogenases 1/2; ALDH2; mitochondrial aldehyde dehyd
مقالات ISI مونوآمین حامل 2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مونوآمین حامل 2; 5-HIAA; 5-hydroxyindolacetic acid; 5-HT; 5-hydroxytryptamine; 5-HTP; 5- hydroxytryptophan; AADC; aromatic L-amino acid decarboxylase; ADR; acute dystonic reaction; BH4; tetrahydrobiopterin; CSF; cerebrospinal fluid; DRD; dopa-responsive dystonia; dRN; dor
Keywords: مونوآمین حامل 2; ADME; absorption/distribution/metabolism/excretion; BBB; blood-brain barrier; CD3OD; tetradeuteromethanol; CDCl3; deuterochloroform; CH2Cl2; dichloromethane; C log D; distribution coefficient; C log P; calculated partition coefficient; CNS; central
Keywords: مونوآمین حامل 2; Oxytocin; Adrenal-medulla; Epinephrine; Norepinephrine; Vesicular monoamine transporter 2;
Keywords: مونوآمین حامل 2; Tyrosine hydroxylase; Norepinephrine transporter; Vesicular monoamine transporter 2; Stellate ganglia; Chronic stress
Keywords: مونوآمین حامل 2; AChE histochemistry; Immunofluorescent labeling; Heart; Intrinsic cardiac neural plexus; Cardiac ganglia; Parasympathetic nerves; Sympathetic nerves; AChE; acetylcholinesterase; Ao; aorta; CGRP; calcitonin gene related peptide; ChAT; choline acetyltransfe
Keywords: مونوآمین حامل 2; 5-HT; serotonin; 5-HTT; serotonin transporter; AMPH; d-amphetamine; ANOVA; analysis of variance; CCD; charge coupled device; COMT; catechol-O-methyltransferase; DA; dopamine; DAT; dopamine transporter; EDTA; ethylenediaminetetraacetic acid; GFAP; glial fi
Keywords: مونوآمین حامل 2; Herbicides; Tyrosine hydroxylase; Dopamine transporter; Vesicular monoamine transporter 2; Antioxidants; Dopamine receptors;
Keywords: مونوآمین حامل 2; 5-HIAA; 5 hydroxyindoleacetic acid; 5-HT; serotonin; 5-HTT; 5-HT transporter; ACTH; adrenocorticotropic hormone; AIAQ; anger irritability and assault questionnaire; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BCG; bacille Calmette-Gueri
Prenatal vitamin D deficiency does not exacerbate behavioural impairments associated with prenatal ethanol exposure in juvenile male mice
Keywords: مونوآمین حامل 2; Juvenile mouse behaviour; Foetal alcohol exposure; Vitamin D deficiency; 25(OH)D; 25-hydroxyvitamin D (calcidiol); Aadc; aromatic L-amino acid decarboxylase; ADHD; attention deficit hyperactivity disorder; ASD; Autism spectrum disorder; COMT; comethyl tra
Aroclor 1254 and BDE-47 inhibit dopaminergic function manifesting as changes in locomotion behaviors in zebrafish embryos
Keywords: مونوآمین حامل 2; Catecholamine; Motor movement; Non-coplanar PCB; PBDE; Zebrafish; DOPAC; 3,4-dihydroxyphenylacetic acid; TH; tyrosine hydroxylase; VMAT2; vesicular monoamine transporter 2;
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease
Keywords: مونوآمین حامل 2; α-Syn; alpha-Synuclein; h-α-Syn; transgenic human alpha-Synuclein; D1 receptor; dopamine receptor type 1; D2 receptor; dopamine receptor type 2; DA; dopamine; DAT; dopamine transporter; VMAT2; vesicular monoamine transporter 2; DOPAC; 3,4-dihydroxypheny
Synthesis and biological evaluation of an 111In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic β-cells
Keywords: مونوآمین حامل 2; BCM; beta cell mass; DTBZ; dihydrotetrabenazine; DTPA; diethylenetriamine-pentaacetic acid; GFP; green fluorescent protein; GLP-1; glucagon-like peptide-1; MIP; mouse insulin I gene promotor; NOD; 1-(1,3-carboxypropyl)-1,4,7-triazacyclononane-4,7-diacetic
Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain
Keywords: مونوآمین حامل 2; VMAT2; Antibody; Monoamine; Immunochemistry; Vesicle; Brain; Localization; Vesicular monoamine transporter 2;
Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
Keywords: مونوآمین حامل 2; 3α-diol; 5α-androstane-3α, 17β-diol; 3β-diol; 5α-androstane-3β, 17β-diol; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; serotonin; DA; dopamine; DAT; dopamine transporter; DHEA; dehydroepiandrosterone; DHP; 5α-dihydroprogesterone; DHT; dihydrotestost
Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells
Keywords: مونوآمین حامل 2; 4-OHAMPH; 4-hydroxyamphetamine; 4-OHNE; 4-hydroxynorephedrine; 5-HTT; serotonin transporter; β-NADH; β-nicotinamide adenine dinucleotide reduced form; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; CHX; cycloheximide; DA; dopamine; D
Photoactivation of ERK/CREB/VMAT2 pathway attenuates MPP+-induced neuronal injury in a cellular model of Parkinson's disease
Keywords: مونوآمین حامل 2; PD; Parkinson's disease; SNpc; substantia nigra pars compacta; DA; dopamine; MPTP; 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine; MPP+; 1-methyl-4-phenylpyridinium; VMAT2; vesicular monoamine transporter 2; LPLI; low-power laser irradiation; Aβ; amyloi
Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry
Keywords: مونوآمین حامل 2; AADC; aromatic L amino acid decarboxylase; COMT; catechol-O-methyl-transferase; CSF; cerebrospinal fluid; 6-OHDA; 6-hydroxydopamine; DBH; dopamine β-hydroxylase; DOPAC; 3,4-dihydroxyphenylacetic acid; 3-MT; 3-methoxytyramine; DA; dopamine; DAT; dopamine
Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington's disease
Keywords: مونوآمین حامل 2; 5-HT; 5-hydroxytryptamine; 7,8-DHF; 7,8-dihydroxyflavone; ACh; acetylcholine; AD; adenosine; ADL; activities of daily living; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; 5â²AMP-activated protein kinase; BDNF; brain-derived neurotro
Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish
Keywords: مونوآمین حامل 2; Vesicular monoamine transporter 2; Anxiety; Zebrafish; VMAT; vesicular monoamine transporter; WT; wild-type; DA; dopamine; 5-HT; 5-hydroxytryptamine; NE; norepinephrine;
Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDD
Keywords: مونوآمین حامل 2; Dopamine; Dopamine transporter; Hexabromocyclododecane; Neurotoxicity; Parkinson disease; Vesicular monoamine transporter 2
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits
Keywords: مونوآمین حامل 2; DAT; dopamine transporter; PD; Parkinson's disease; DAT-tg; dopamine transporter over-expressing transgenic; DAT-KO; dopamine transporter knock-out; VMAT2; vesicular monoamine transporter 2; VMAT2-kd; vesicular monoamine transporter 2 knock-down; MPTP; 1-
Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons
Keywords: مونوآمین حامل 2; Dopamine; D2 autoreceptors; KATP channels; HCN channels; Brain slice; ACSF; artificial cerebrospinal fluid; ATP; adenosine triphosphate; DA; dopamine; DAT; dopamine transporter; GIRK; G protein-coupled inwardly rectifying potassium channels; HCN; hyperpol
The expression of vesicular glutamate transporter 3 and vesicular monoamine transporter 2 induced by brain-derived neurotrophic factor in dorsal root ganglion neurons in vitro
Keywords: مونوآمین حامل 2; Brain-derived neurotrophic factor; Vesicular glutamate transporter 3; Vesicular monoamine transporter 2; Neuron; Dorsal root ganglion
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
Keywords: مونوآمین حامل 2; Enzyme active site structure; Presynaptic inhibition; Exocytotic and non-exocytotic release; Neuroprotection; Parkinson's disease; Affective disorders; MAO; monoamine oxidase; MAO-A; monoamine oxidase isoform A; MAO-B; monoamine oxidase isoform B; COMT; c
Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson's disease
Keywords: مونوآمین حامل 2; Vesicular monoamine transporter 2; SNP; Association; Parkinson's disease;
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
Keywords: مونوآمین حامل 2; Tardive dyskinesia; Schizophrenia; Pharmacogenetics; Vesicular monoamine transporter 2 (VMAT2/SLC18A2); (TD); tardive dyskinesia; (VMAT2); vesicular monoamine transporter 2; (CATIE); Clinical Antipsychotic Trials of Intervention Effectiveness; (SNP); sing
Research ReportRNA interference targeting α-synuclein attenuates methamphetamine-induced neurotoxicity in SH-SY5Y cells
Keywords: مونوآمین حامل 2; METH; methamphetamine; α-syn; α-synuclein; LBs; Lewy bodies; DA; dopamine; TH; tyrosine hydroxylase; DAT; dopamine transporter; VMAT-2; vesicular monoamine transporter 2; ROS; reactive oxygen species; NOS; nitric oxide synthase; NO; nitrogen monoxide; Î
Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: Role of dopamine handling in neurotoxicity
Keywords: مونوآمین حامل 2; Polybrominated diphenyl ethers; Dopamine; Striatum; Vesicular monoamine transporter 2; DE-71; Parkinson's disease;
Imaging of VMAT2 binding sites in the brain by 18F-AV-133: The effect of a pseudo-carrier
Keywords: مونوآمین حامل 2; PET imaging; Parkinson's disease; Vesicular monoamine transporter 2; Brain imaging and pseudo-carrier effect
Novel pancreatic beta cell-specific proteins: Antibody-based proteomics for identification of new biomarker candidates
Keywords: مونوآمین حامل 2; HPA; human protein atlas; IHC; immunohistochemistry; GLP-1R; glucagon-like peptide 1 receptor; PET; positron emission tomography; T1D; type 1 diabetes; T2D; type 2 diabetes; TMA; tissue microarray; VMAT2; vesicular monoamine transporter 2; Beta cell bioma
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse
Keywords: مونوآمین حامل 2; α-syn; α-synuclein; ASK1; Apoptosis signaling-regulating kinase 1; CMA; Chaperone-mediated autophagy; DAT; Dopamine transporter; ETC; Electron transport chain; iPS; Induced pluripotent stem; LAMP-2A; Lysosome-associated membrane protein 2A; LB; Lewy bod
Synuclein modulation of monoamine transporters
Keywords: مونوآمین حامل 2; α-Syn; α-synuclein; β-Syn; β-synuclein; γ-Syn; γ-synuclein; AD; Alzheimer's disease; CNS; central nervous system; DA; dopamine; DAT; dopamine transporter; DMI; desipramine; MAT; presynaptic plasma membrane monoamine transporters; NAC; non-Aβ comp
Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: Locomotor activity, drug discrimination and self-administration
Keywords: مونوآمین حامل 2; Methamphetamine; Tetrabenazine; Vesicular monoamine transporter 2; Self-administration; Locomotor activity; Discriminative stimulus
Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: Examining synapsin II in the pathophysiology of schizophrenia
Keywords: مونوآمین حامل 2; aCSF; artificial cerebral spinal fluid; ADON; antisense deoxyoligonucleotide; ANOVA; analysis of variance; APD; antipsychotic drug; cm; centimeter; DA; dopamine; dB; decibel; IP; intraperitoneally; MM; mismatch oligonucleotide; MPFC; medial prefrontal cor
Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways
Keywords: مونوآمین حامل 2; CREB; cAMP-response element-binding protein; DA; dopamine; DAT; dopamine transporter; DOPAC; 3,4-dihydroxyphenylacetic acid; ERK; extracellular signal-regulated kinase; GPER1; G protein-coupled estrogen receptor 1; GSK3β; glycogen synthase kinase 3β; HV
An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2
Keywords: مونوآمین حامل 2; Vesicular monoamine transporter 2; Nucleophilic fluorination; [18F]AV-133; Automatic synthesis; PET
Chronic low dose Adderall XR® down-regulates cfos expression in infantile and prepubertal rat striatum and cortex
Keywords: مونوآمین حامل 2; Amphetamine; methylphenidate; development; liquid chromatography-mass spectrometry; ADD; Adderall XR®; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; arc; activity regulated cytoskeletal associated; bdnf; brain derived neurotrophic
Prosurvival effect of human wild-type α-synuclein on MPTP-induced toxicity to central but not peripheral catecholaminergic neurons isolated from transgenic mice
Keywords: مونوآمین حامل 2; α-synuclein transgenic mice; Parkinson's disease; protection against MPTP; nigrostriatal system; peripheral nervous system; α-SYN; alpha-synuclein; DA; dopamine; DAB; 3,3â²-diaminobenzidine; DAT; dopamine transporter; DOPAC; 3,4-dihydroxyphenyl acetic
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an 18F epoxide derivative of tetrabenazine
Keywords: مونوآمین حامل 2; (+)FP-DTBZ, (+)2, 9-fluoropropyl-(+)dihydrotetrabenazine; (+)-DTBZ, (+)dihydrotetrabenazine; (±)-TBZ, (±)tetrabenazine; VMAT2, vesicular monoamine transporter 2Beta cell mass; Vesicular monoamine transporter 2; Diabetes; Tetrabenazine; PET
Emerging restorative treatments for Parkinson's disease
Keywords: مونوآمین حامل 2; Ad; adenovirus; AAV; adeno-associated virus; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; bFGF; basic fibroblast growth factor; CD45; cluster of differentiation 45; CNTF; ciliary neurotrophic factor; CSF; cerebrospinal fluid; DAT;
Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of l-5-hydroxytryptophan
Keywords: مونوآمین حامل 2; amphetamine; ecstasy; 5-HT transporter; RTI-55; binding; DA; dopamine; HPLC-ECD; high pressure liquid chromatography with electrochemical detection; MDMA; (±)-3,4-methylenedioxymethamphetamine; PBS; phosphate-buffered saline; SERT; 5-HT transporter; TP-2
Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra
Keywords: مونوآمین حامل 2; Vesicular monoamine transporter 2; Lewy bodies; Parkinson's disease; Diffuse Lewy body disease; Immunohistochemistry
Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells
Keywords: مونوآمین حامل 2; DAT; dopamine transporter; DA; dopamine; DAergic; dopaminergic; EGFP; enhanced green fluorescent protein; AMPT; α-methyl-p-tyrosine; PNS; postnuclear supernatant; Syn; synaptophysin; TH; tyrosine hydroxylase; TBZ; tetrabenazine; VMAT2; vesicular monoamin
Perinatal Heptachlor Exposure Increases Expression of Presynaptic Dopaminergic Markers in Mouse Striatum
Keywords: مونوآمین حامل 2; Heptachlor; Developmental neurotoxicity; Dopamine transporter; Vesicular monoamine transporter 2; Parkinson's disease; Tyrosine hydroxylase;
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease
Keywords: مونوآمین حامل 2; Nurr1; Transcriptional factor; Dopaminergic neuron; Parkinson's disease; Polymorphisms; AADC; l-aromatic amino acid decarboxylase; ADH2; retinoid acid converting enzyme; AF1; N-terminal region; BDNF; brain-derived neurotrophic factor; CRE; cAMP-response e
Pharmacogenetics of the serotonin transporter
Keywords: مونوآمین حامل 2; ACC; anterior cingulate cortex; OCD; obsessive-compulsive disorder; 5HT; serotonin; 5HTT; serotonin transporter; 5HTTLPR; serotonin transporter gene-linked polymorphic region; 5HIAA; 5-hydroxyindoleacetic acid; SSRI; selective serotonin reuptake inhibitor